Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2021-02-08
4:43 pm
Sale
13GAIM ImmunoTech Inc.
AIM
Hudson Bay Capital Management LP7,747
0.02%
-909,451decrease
(-99.16%)
View
2020-02-14
4:31 pm
Sale
13GAIM ImmunoTech Inc.
AIM
Anson Funds Management LP434,030
4.9%
-843,192decrease
(-66.02%)
View
2020-01-31
1:45 pm
Purchase
13GAIM ImmunoTech Inc.
AIM
Hudson Bay Capital Management LP917,198
9.99%
917,198increase
(New Position)
View
2019-09-30
06:14 am
Purchase
13GAIM ImmunoTech Inc.
AIM
Anson Funds Management LP1,277,222
9.9%
1,277,222increase
(New Position)
View
2019-06-28
4:05 pm
Sale
13DAIM ImmunoTech Inc.
AIM
Equels Thomas K120,498
5.3%
-3,758,416decrease
(-96.89%)
View
2019-06-18
4:04 pm
Purchase
13DAIM ImmunoTech Inc.
AIM
Equels Thomas K3,878,914
4.2%
3,878,914increase
(New Position)
View
2019-04-09
1:51 pm
Purchase
13DAIM ImmunoTech Inc.
AIM
Equels Thomas K3,976,414
5.9%
3,976,414increase
(New Position)
View
2019-04-05
12:08 pm
Purchase
13GAIM ImmunoTech Inc.
AIM
Iliad Research & Trading, L.P.6,222,802
9.99%
6,222,802increase
(New Position)
View
2019-01-04
2:22 pm
Sale
13GAIM ImmunoTech Inc.
AIM
SABBY MANAGEMENT, LLC2,404,660
11%
-895,340decrease
(-27.13%)
View
2018-04-24
09:32 am
Purchase
13GAIM ImmunoTech Inc.
AIM
SABBY MANAGEMENT, LLC3,300,000
11%
1,715,115increase
(+108.22%)
View